214 related articles for article (PubMed ID: 27809896)
1. The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.
Kampstra AS; van Heemst J; Moustakas AK; Papadopoulos GK; Huizinga TW; Toes RE
Arthritis Res Ther; 2016 Nov; 18(1):254. PubMed ID: 27809896
[TBL] [Abstract][Full Text] [Related]
2. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
Scally SW; Law SC; Ting YT; Heemst JV; Sokolove J; Deutsch AJ; Bridie Clemens E; Moustakas AK; Papadopoulos GK; van der Woude D; Smolik I; Hitchon CA; Robinson DB; Ferucci ED; Bernstein CN; Meng X; Anaparti V; Huizinga T; Kedzierska K; Reid HH; Raychaudhuri S; Toes RE; Rossjohn J; El-Gabalawy H; Thomas R
Ann Rheum Dis; 2017 Nov; 76(11):1915-1923. PubMed ID: 28801345
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets.
James EA; Moustakas AK; Bui J; Papadopoulos GK; Bondinas G; Buckner JH; Kwok WW
Arthritis Rheum; 2010 Oct; 62(10):2909-18. PubMed ID: 20533291
[TBL] [Abstract][Full Text] [Related]
5. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
7. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.
Law SC; Street S; Yu CH; Capini C; Ramnoruth S; Nel HJ; van Gorp E; Hyde C; Lau K; Pahau H; Purcell AW; Thomas R
Arthritis Res Ther; 2012 May; 14(3):R118. PubMed ID: 22594821
[TBL] [Abstract][Full Text] [Related]
8. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
[TBL] [Abstract][Full Text] [Related]
9. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
Balandraud N; Auger I; Roudier J
J Autoimmun; 2021 Jan; 116():102542. PubMed ID: 32928608
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Hill JA; Southwood S; Sette A; Jevnikar AM; Bell DA; Cairns E
J Immunol; 2003 Jul; 171(2):538-41. PubMed ID: 12847215
[TBL] [Abstract][Full Text] [Related]
11. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.
Ting YT; Petersen J; Ramarathinam SH; Scally SW; Loh KL; Thomas R; Suri A; Baker DG; Purcell AW; Reid HH; Rossjohn J
J Biol Chem; 2018 Mar; 293(9):3236-3251. PubMed ID: 29317506
[TBL] [Abstract][Full Text] [Related]
12. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
[TBL] [Abstract][Full Text] [Related]
13. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
14. Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
van Heemst J; Jansen DT; Polydorides S; Moustakas AK; Bax M; Feitsma AL; Bontrop-Elferink DG; Baarse M; van der Woude D; Wolbink GJ; Rispens T; Koning F; de Vries RR; Papadopoulos GK; Archontis G; Huizinga TW; Toes RE
Nat Commun; 2015 May; 6():6681. PubMed ID: 25942574
[TBL] [Abstract][Full Text] [Related]
15. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC
Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
[TBL] [Abstract][Full Text] [Related]
16. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
Zanelli E; Krco CJ; David CS
J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
[TBL] [Abstract][Full Text] [Related]
17. HLA shared epitope and ACPA: just a marker or an active player?
Pratesi F; Petit Teixeira E; Sidney J; Michou L; Puxeddu I; Sette A; Cornelis F; Migliorini P
Autoimmun Rev; 2013 Oct; 12(12):1182-7. PubMed ID: 23958703
[TBL] [Abstract][Full Text] [Related]
18. How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model.
Roudier J; Balandraud N; Auger I
Front Immunol; 2022; 13():930112. PubMed ID: 35774784
[TBL] [Abstract][Full Text] [Related]
19. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis.
Scally SW; Petersen J; Law SC; Dudek NL; Nel HJ; Loh KL; Wijeyewickrema LC; Eckle SB; van Heemst J; Pike RN; McCluskey J; Toes RE; La Gruta NL; Purcell AW; Reid HH; Thomas R; Rossjohn J
J Exp Med; 2013 Nov; 210(12):2569-82. PubMed ID: 24190431
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
